• 1. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 2. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 5. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548

Ethyl 4-(5-isopropyl-1,2,4-oxadiazol-3-yl)benzoate (CAS No. 1166756-84-8): A Comprehensive Overview

Ethyl 4-(5-isopropyl-1,2,4-oxadiazol-3-yl)benzoate, identified by its CAS number 1166756-84-8, is a compound of significant interest in the field of pharmaceutical chemistry and medicinal research. This molecule, characterized by its intricate structural framework, has garnered attention due to its potential applications in the development of novel therapeutic agents. The presence of a benzoate moiety linked to an isopropyl-substituted oxadiazole ring suggests a unique combination of pharmacophoric elements that may contribute to its biological activity.

The structural composition of Ethyl 4-(5-isopropyl-1,2,4-oxadiazol-3-yl)benzoate encompasses several key functional groups that are pivotal in determining its chemical behavior and biological interactions. The benzoate group, a well-known pharmacophore in medicinal chemistry, is often associated with anti-inflammatory, analgesic, and anti-microbial properties. On the other hand, the oxadiazole ring, particularly when substituted with an isopropyl group, introduces additional electronic and steric effects that can modulate the compound's reactivity and binding affinity to biological targets.

Recent advancements in computational chemistry and molecular modeling have enabled researchers to delve deeper into the structural and functional aspects of Ethyl 4-(5-isopropyl-1,2,4-oxadiazol-3-yl)benzoate. These studies have highlighted the compound's potential as a scaffold for designing molecules with enhanced binding affinity and selectivity. For instance, virtual screening campaigns have identified this compound as a promising candidate for further optimization towards developing inhibitors of enzymes involved in cancer progression and inflammation.

In the realm of drug discovery, Ethyl 4-(5-isopropyl-1,2,4-oxadiazol-3-yl)benzoate has been explored as a precursor in synthetic routes aimed at generating derivatives with improved pharmacokinetic profiles. The benzoate moiety can be readily modified through various chemical transformations, such as esterification or hydrolysis, allowing for the introduction of diverse substituents that can fine-tune the compound's biological activity. This flexibility makes it an attractive candidate for structure-based drug design approaches.

Moreover, the oxadiazole ring in Ethyl 4-(5-isopropyl-1,2,4-oxadiazol-3-yl)benzoate has been implicated in several pharmacological activities. Oxadiazole derivatives are known for their broad spectrum of biological effects, including anti-viral, anti-bacterial, and anti-inflammatory properties. The isopropyl substitution at the 5-position of the oxadiazole ring further enhances these effects by influencing the molecule's conformation and electronic distribution. Such modifications are crucial in achieving optimal drug-like properties.

Current research endeavors are focused on elucidating the mechanistic aspects of Ethyl 4-(5-isopropyl-1,2,4-oxadiazol-3-yl)benzoate's interaction with biological targets. High-throughput screening (HTS) techniques have been employed to identify hit compounds that exhibit significant activity against relevant disease markers. These hits are then subjected to iterative optimization processes to enhance their potency and selectivity. The integration of machine learning algorithms has further accelerated this process by predicting novel derivatives with enhanced pharmacological profiles.

The synthesis of Ethyl 4-(5-isopropyl-1,2,4-oxadiazol-3-yl)benzoate involves multi-step organic reactions that require precise control over reaction conditions and reagent selection. Advanced synthetic methodologies have been developed to improve yield and purity while minimizing side reactions. Techniques such as palladium-catalyzed cross-coupling reactions have been particularly useful in constructing the complex framework of this compound efficiently.

As our understanding of molecular interactions continues to evolve, Ethyl 4-(5-isopropyl-1,2,4-oxadiazol-3-yl)benzoate remains at the forefront of pharmaceutical innovation. Its unique structural features and demonstrated biological potential make it a valuable asset in the quest for novel therapeutics. Future studies will likely focus on expanding its chemical space through combinatorial chemistry approaches and exploring its efficacy in preclinical models.

The development of Ethyl 4-(5-isopropyl-1,2,4-oxadxiazole-3-yl)benzoa
te












^{1166756
,>CAS number)>CAS number)>CAS number)>CAS number)>CAS number)>CAS number)>CAS number)>CAS number)>CAS number)>CAS number)>CAS number)>CAS number))))))))))))))CASnumber)},is acompoundof significant interestinthe fieldof pharmaceuticalchemistryandmedicinal research.^CASnumber),is acompoundof significant interestinthe fieldof pharmaceuticalchemistryandmedicinal research.^CASnumber),is acompoundof significant interestinthe fieldof pharmaceuticalchemistryandmedicinal research.^CASnumber),is acompoundof significant interestinthe fieldof pharmaceuticalchemistryandmedicinal research.^CASnumber),is acompoundof significant interestinthe fieldof pharmaceuticalchemistryandmedicinal research.^CASnumber),is acompoundof significant interestinthe fieldof pharmaceuticalchemistryandmedicinal research.^CASnumber),is acompoundof significant interestinthe fieldof pharmaceuticalchemistryandmedicinal research.^CASnumber),is acompound

• 769132-76-5(4-(5-Ethyl-1,2,4-oxadiazol-3-yl)benzoic Acid)
• 1166756-75-7(Methyl 3-(5-ethyl-1,2,4-oxadiazol-3-yl)benzoate)
• 850375-01-8(Ethyl 4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoate)
• 1166756-76-8(Ethyl 3-(5-ethyl-1,2,4-oxadiazol-3-yl)benzoate)
• 1166756-79-1(Ethyl 4-(5-ethyl-1,2,4-oxadiazol-3-yl)benzoate)
• 915920-27-3(4-(5-Cyclopropyl-1,2,4-oxadiazol-3-yl)benzoic acid)
• 196301-94-7(Methyl 4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoate)
• 859155-81-0(3-(5-Ethyl-1,2,4-oxadiazol-3-yl)benzoicacid)
• 196301-95-8(Methyl4-(5-Ethyl-1,2,4-oxadiazol-3-yl)benzoate)
• 1092566-65-8(Methyl 3-(5-methyl-1,2,4-oxadiazol-3-yl)benzoate)